Octant Gets FDA Orphan Drug Designation for OCT-980
The FDA granted orphan drug designation to Octant’s OCT-980 for treating retinitis pigmentosa.
Related stories
Modi’s Office Summons Telecom Secretary Over Website Takedowns
Government sources say the summons follows Reuters revelations that website takedowns were based on fake court orders.
M impact | REGULATION | Nov 14, 2026, 07:58 AM UTC
China Says Both Sides Discussed Reciprocal Tariff Cuts Worth $30 Billion Each
China’s Commerce Ministry said the sides discussed tariffs, reciprocal tariff cuts worth $30 billion on each side, agricultural trade and other issues.
L impact | REGULATION | Nov 14, 2026, 06:56 AM UTC
China to Add Pfizer GLP-1 Drug to State Health Insurance Scheme
M impact | REGULATION | Nov 14, 2026, 06:02 AM UTC
China to Add JW Therapeutics’ CAR-T Therapy to State Insurance
China’s National Healthcare Security Administration says JW Therapeutics’ CAR-T therapy will be added to the state-run health insurance scheme.
L impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
China to Add JW Therapeutics CAR-T Therapy to State Health Insurance
China's National Healthcare Security Administration says JW Therapeutics' CAR-T therapy will be added to the state-run health insurance scheme.
M impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
Trump Administration Seeks $50 Billion for Air Traffic Control After Outage
The administration boosted its request for air traffic control funding to $50 billion after a communications issue forced a nationwide groundstop, halting thousands of flights for
M impact | REGULATION | Nov 14, 2026, 02:44 AM UTC